290
Participants
Start Date
Not specified
Study Completion Date
September 30, 1994
Primaquine
Sulfamethoxazole-Trimethoprim
Dapsone
Clindamycin
Beth Israel Med. Ctr. (Mt. Sinai), New York
NY Univ. HIV/AIDS CRS, New York
Cornell University A2201, New York
SUNY - Buffalo, Erie County Medical Ctr., Buffalo
Univ. of Rochester ACTG CRS, Rochester
Pitt CRS, Pittsburgh
Unc Aids Crs, Chapel Hill
Carolinas HealthCare System, Carolinas Med. Ctr., Charlotte
The Ohio State Univ. AIDS CRS, Columbus
Case CRS, Cleveland
Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis
Methodist Hosp. of Indiana, Indianapolis
University of Minnesota, ACTU, Minneapolis
Rush Univ. Med. Ctr. ACTG CRS, Chicago
Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU, New Orleans
USC CRS, Los Angeles
Harbor-UCLA Med. Ctr. CRS, Torrance
Univ. of Hawaii at Manoa, Leahi Hosp., Honolulu
Stanford CRS, Palo Alto
Ucsf Aids Crs, San Francisco
Santa Clara Valley Med. Ctr., San Jose
San Mateo County AIDS Program, San Mateo
University of Colorado Hospital CRS, Aurora
Northwestern University CRS, Chicago
Johns Hopkins Adult AIDS CRS, Baltimore
Washington U CRS, St Louis
NYU Med. Ctr., Dept. of Medicine, New York
Regional Center for Infectious Disease, Wendover Medical Center CRS, Greensboro
Univ. of Cincinnati CRS, Cincinnati
University of Washington AIDS CRS, Seattle
Massachusetts General Hospital ACTG CRS, Boston
Beth Israel Deaconess - East Campus A0102 CRS, Boston
Collaborators (2)
Jacobus Pharmaceutical
INDUSTRY
Glaxo Wellcome
INDUSTRY
National Institute of Allergy and Infectious Diseases (NIAID)
NIH